公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 |
---|---|---|---|---|---|---|
2006 | Earnings forecast disclosure regulation and earnings management: Evidence from Taiwan IPO firms | Jaggi B.; Chin C.-L.; HSIOU-WEI W. LIN ; Lee P. | Review of Quantitative Finance and Accounting | |||
2018 | Fibroblast-stimulating lipopeptide-1 as a potential mucosal adjuvant enhances mucosal and systemic immune responses to enterovirus 71 vaccine | Lin Y.-L.; Cheng P.-Y.; Chin C.-L.; LI-MIN HUANG ; Lin S.-Y.; BOR-LUEN CHIANG | Vaccine | 8 | 8 | |
2011 | On the association between IPO underpricing and reversal and Taiwan's regulatory reforms for mandatory forecasts | Chin C.-L.; HSIOU-WEI W. LIN ; Syu Y.-J.E. | Journal of Forecasting | |||
2020 | A Polysaccharide Purified From Ganoderma lucidum Acts as a Potent Mucosal Adjuvant That Promotes Protective Immunity Against the Lethal Challenge With Enterovirus A71 | Lin Y.-L.; Shih C.; Cheng P.-Y.; Chin C.-L.; Liou A.-T.; Lee P.-Y.; BOR-LUEN CHIANG | Frontiers in Immunology | 11 | 9 |